aspirin and 11-dehydro-thromboxane b2

aspirin has been researched along with 11-dehydro-thromboxane b2 in 127 studies

Research

Studies (127)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (3.15)	18.7374
1990's	29 (22.83)	18.2507
2000's	42 (33.07)	29.6817
2010's	48 (37.80)	24.3611
2020's	4 (3.15)	2.80

Authors

Authors	Studies
Björck, T; Dahlén, B; Dahlén, SE; Granström, E; Kumlin, M; Zetterström, O	1
Bizzi, B; Castellana, MA; Ciabattoni, G; Landolfi, R; Patrignani, P; Patrono, C; Pogliani, E	1
Hayashi, Y; Nakahama, H; Nakanishi, T; Shimizu, S; Sugita, M; Takiguchi, A; Uyama, O; Yamamoto, S	1
Kawano, K; Kimura, B; Konno, S; Tamura, K; Tohgi, H	1
Albanese, S; Bianchi, C; Ciabattoni, G; Coppola, E; Lanza, GA; Natale, A; Rebuzzi, AG	1
Fitzgerald, DJ; FitzGerald, GA; Mayo, G; Murray, R; Rocki, W	1
Averna, M; Catalano, I; Ciabattoni, G; Davì, G; Notarbartolo, A; Patrono, C; Strano, A	1
Born, GV; Ciabattoni, G; Fragasso, G; Hackett, D; Lipkin, DP; Maseri, A; Patrono, C; Vejar, M	1
Catella, F; Fitzgerald, GA; Lupinetti, MD; Sheller, JR	1
Catella, F; Fitzgerald, DJ; FitzGerald, GA; Lawson, JA	1
Ciabattoni, G; Fitzgerald, GA; Lawson, JA; Patrono, C	1
Catella, F; FitzGerald, GA; Healy, D; Lawson, JA	1
Antinori, A; Ciabattoni, G; De Candia, E; Landolfi, R; Masetti, R; Patrono, C; Rocca, B	1
Matsui, Y; Michishita, H; Shimizu, S; Sugita, M; Uyama, O	1
Hjemdahl, P; Larsson, PT; Wallén, NH	1
Chiabrando, C; Djurup, R; Fanelli, R; Foegh, M; Joergensen, PN; Jörres, A; Soerensen, HU	1
Alberti, E; Bonollo, M; Chiabrando, C; Djurup, R; Fanelli, R; Rivoltella, L	1
Sladek, K; Szczeklik, A	1
Bachir, D; Foulon, I; Galacteros, F; Maclouf, J	1
Minton, TA; Morrow, JD	1
Andreotti, F; Ciabattoni, G; Davies, G; Maseri, A; Patrono, C; Simonetti, BM; Sritara, P; Ujang, S	1
Hayashi, Y; Haze, K; Imanishi, M; Kuramochi, M; Nonogi, H; Omae, T; Oshima, S; Yamamoto, S; Yasu, T	1
Delanty, N; FitzGerald, GA; Lawson, JA; Reilly, M	1
Akiyama, K; Kobayashi, M; Mita, H; Mizushima, Y; Oosaki, R; Shida, T	1
Gullichsen, E; Kuttila, K; Mucha, I; Nelimarkka, O; Niinikoski, J; Rautanen, M; Riutta, A	1
Alessandrini, P; Bon, GB; Bucciarelli, T; Ciabattoni, G; Cipollone, F; Costantini, F; Davi, G; Mezzetti, A; Minotti, G; Patrono, C	1
Alessandri, C; Basili, S; Cipollone, F; Cordova, C; Davì, G; Gazzaniga, P; Santarone, S; Vieri, M; Violi, F	1
Basili, S; Cordova, C; Fitzgerald, GA; Praticò, D; Vieri, M; Violi, F	1
Guzzo, C; Lazarus, G; Mitchell, TA; Morrow, JD; Oates, JA; Roberts, LJ; Zackert, WE	1
Ciabattoni, G; Grobbee, DE; Kluft, C; Koudstaal, PJ; Patrono, C; van Kooten, F	1
Hishinuma, T; Matsumura, E; Mizugaki, M; Murai, Y; Tamai, M; Yamanobe, S; Yamazaki, T	1
Basili, S; Ciabattoni, G; Cipollone, F; Davì, G; Di Franco, M; Ferro, D; Roccaforte, S	1
Beck, O; Fitzgerald, D; Granström, E; Harhen, B; Hjemdahl, P; Perneby, C	1
Belton, O; Byrne, D; Fitzgerald, DJ; Kearney, D; Leahy, A	1
Alvord, MA; Carroll, AA; Ens, GE; Fritsma, GA; Jensen, R	1
Bang, NU; Biller, J; Bruno, A; Cheryk, LA; Durocher, A; Fleck, JD; McConnell, JP; Meschia, JF; Williams, L	1
Akiyama, K; Endoh, S; Kawagishi, Y; Kobayashi, M; Kudoh, M; Mita, H; Taniguchi, M	1
Bang, NU; Bruno, A; Cohen, SN; Mansbach, HH; McConnell, JP; Tietjen, GE	1
Kawano, T; Kohno, S; Matsuse, H; Mitsuta, K; Obase, Y; Shimoda, T; Tomari, SY	1
Eikelboom, JW; Hirsh, J; Johnston, M; Weitz, JI; Yi, Q; Yusuf, S	1
del Soldato, P; Fiorucci, S; Lechi, A; Mencarelli, A; Meneguzzi, A; Minuz, P; Morelli, A	1
Altman, R; Rouvier, J; Scazziota, A	1
Cipollone, F; Cuccurullo, F; Di Gregorio, D; Ganci, A; Greco, A; Mezzetti, A; Panara, MR; Pasquale, M; Patrignani, P; Porreca, E	1
Bovill, E; Cornell, E; Feinberg, WM; Hart, RG; Leonard, AD; Pearce, LA; Talbert, RL	1
Bang, NU; Bruno, A; Cohen, SN; Gorelick, PB; McConnell, JP; Tietjen, GE; Wallis, RA	1
Andreotti, F; Ikonomidis, I; Nihoyannopoulos, P	1
Dippel, DW; Koudstaal, PJ; Leebeek, FW; Li, SS; Mehicevic, A; Van Kooten, F; van Vliet, HH	1
Capone, ML; Di Gregorio, P; Grana, M; Merciaro, G; Minuz, P; Patrignani, P; Patrono, C; Ricciotti, E; Sciulli, MG; Tacconelli, S	1
FitzGerald, GA; Hennekens, CH; Schror, K; Weisman, S	1
Koivisto, AM; Mäenpää, J; Riutta, A; Vainio, M	1
Acuña, C; Corral, J; Gonzalez-Conejero, R; Guerrero, JA; Rivera, J; Vicente, V	1
Capone, ML; Carnevale, V; Filabozzi, P; Grana, M; Padovano, R; Patrignani, P; Ricciotti, E; Sciulli, MG; Tacconelli, S	1
Hillbom, M; Juvela, S; Pyhtinen, J; Riutta, A; Saloheimo, P	1
Andreotti, F; Ikonomidis, I; Lekakis, J; Nihoyannopoulos, P; Vamvakou, G	1
Anders, C; Haubelt, H; Hellstern, P	1
Avellone, G; Ballone, E; Ciabattoni, G; Davì, G; Di Febbo, C; Di Nicola, M; Falco, A; Pinto, A; Salvati, F; Vitacolonna, E	1
Basili, S; Ciabattoni, G; Cipollone, F; Consoli, A; Davì, G; Devangelio, E; Falco, A; Mezzetti, A; Patrono, C; Santilli, F; Taraborelli, T	1
Bucciarelli, T; Ciabattoni, G; Davì, G; Del Re, L; Di Febbo, C; Di Iorio, A; Falco, A; Giusti, C; Paganelli, R; Patrono, C; Pescara, L; Porreca, E; Sau, A	1
Golanski, J; Markuszewski, L; Rosiak, M; Rysz, J; Spychalska, M; Watala, C	1
Kobayashi, Y; Madoiwa, S; Mimuro, J; Nonaka, T; Ohmori, T; Ozaki, Y; Sakata, Y; Yatomi, Y	1
Becker, DM; Becker, LC; Bray, PF; Faraday, N; Herrera-Galeano, JE; Moy, TF; Segal, JB; Yanek, LR	1
Capone, ML; D'Amelio, E; De Caterina, R; Grana, M; Patrignani, P; Patrono, C; Price, TS; Renda, G; Sacchetta, D; Santarelli, F; Sciulli, MG; Tacconelli, S; Zimarino, M; Zurro, M	1
Fitzgerald, DJ; Maree, AO	1
Bray, MS; Couper, DJ; Heiss, G; Lee, CR; North, KE; Zeldin, DC	1
Abderazek, F; Addad, F; Ben-Farhat, M; Ben-Hamda, K; Chakroun, T; Elalamy, I; Gamra, H; Hamdi, S; Hassine, M; Samama, MM	1
Fixler, DE; Heistein, LC; Journeycake, JM; Lemler, MS; Ramaciotti, C; Scott, WA; Zellers, TM	1
Ens, G; Geske, FJ; Guyer, KE	1
Brace, LD; Cursio, J; Grossi, E; Helgason, CM; Pandey, D; Valika, A	1
Hartman, SJ; Jaffe, AS; Karon, BS; McConnell, JP; Santrach, PJ; Scott, R; Wockenfus, A	1
Dukat, A; Kriska, M; Rajec, J; Risnyovszki, Z; Sapak, M; Vojtko, R	1
Bhatt, DL; Easton, JD; Eikelboom, JW; Fox, KA; Hamm, C; Hankey, GJ; Hu, T; Johnston, SC; Mak, KH; Montalescot, G; Steg, PG; Steinhubl, SR; Thom, J; Topol, EJ	1
Davì, G; Liani, R; Pettinella, C; Romano, M; Santilli, F; Stuppia, L	1
Abderazek, F; Addad, F; Ben-Farhat, M; Chakroun, T; Dridi, Z; Elalamy, I; Gamra, H; Hamdi, S; Hassine, M; Samama, MM	1
Antonino, MJ; Bliden, KP; Coppolecchia, R; Gurbel, PA; Mahla, E; Tantry, US	1
Cattaneo, M	1
Blais, N; Diodati, JG; Lordkipanidzé, M; Merhi, Y; Pharand, C; Sia, YK	1
Drolet, M; Herzog, W; Karon, H; Mitchell, BD; Newcomer, S; Pakyz, R; Ryan, KA; Sack, P; Shen, H; Shi, X; Shuldiner, AR; Zhao, Y	1
Ciabattoni, G; Davì, G; Dragani, A; Ferrante, E; Habib, A; Lattanzio, S; Mattoscio, D; Mucci, L; Pascale, S; Patrono, C; Petrucci, G; Ranelletti, FO; Recchiuti, A; Rocca, B	1
Carroll, RC; Craft, RM; Dakin, PA; Jarrett, A; Scott, J; Snider, CC; Wortham, DC; Worthington, RE	1
Ballagulah, M; Cassel, A; Erport, A; Kohanovsky, E; Pizov, R; Quitt, M; Zisman, E	1
Baker, LD; Breitner, JC; Milne, G; Montine, TJ; Sonnen, JA	1
Adámek, T; Alusik, S; Lejsková, M; Paluch, Z	1
Alfieris, GM; Blumberg, N; Cholette, JM; Lerner, NB; Mamikonian, L	1
Dharmasaroja, PA; Sae-Lim, S	1
Davis-Gorman, G; McDonagh, PF; Peterson, J; Stump, CS; Thomson, SS; Yassine, HN	1
Cuccurullo, C; Davì, G; Di Iorio, P; Di Michele, D; Di Ruscio, P; Ferrante, E; Lattanzio, S; Laurora, G; Lessiani, G; Liani, R; Sgrò, G; Simeone, E; Vazzana, N	1
Gremmel, T; Kopp, CW; Koppensteiner, R; Panzer, S; Seidinger, D; Steiner, S	1
Alves, MT; Bosco, AA; Carvalho, Md; Dusse, LM; Fernandes, AP; Freitas, FR; Gomes, KB; Gonçalves, LH; Komatsuzaki, F; Pianett, GA; Rodrigues, KF; Sóter, MO; Sousa, MO	1
Deev, AD; Dobrovol'skiĭ, AB; Katkova, OV; Laguta, PS; Panchenko, EP; Titaeva, EV	1
Adefurin, A; Ford, I; Greaves, M; Halawani, SH; Webster, J; Williams, DJ	1
Gao, F; Men, J; Modi, P; Ren, J; Wang, Z; Wei, M	1
Huras, H; Jach, R; Musiał, J; Reroń, A; Rytlewski, K; Undas, A; Wilczak, M; Wójtowicz, A	1
Gao, F; Men, JL; Ren, J; Wang, ZX; Wei, MX	1
Arnetz, L; Brismar, K; Hjemdahl, P; Li, N; Östenson, CG; Spectre, G	1
Byron, JK; Hoh, CM; McMichael, MA; Smith, SA	1
Bähler, L; Gerdes, VE; Hoekstra, JB; Holleman, F; Kamphuisen, PW; Lemkes, BA; Nieuwland, R; Stroobants, AK; Van Den Dool, EJ	1
Eikelboom, JW; Hirsh, J; Johnston, MA; Li, C; Xie, C	1
Arieselia, Z; Baziad, A; Hartanto, MD; Setiabudy, R; Setiawati, A	1
Alusik, S; Bednar, F; Mottlova, J; Paluch, Z; Sadilkova, L	2
Chi, L; Han, Z; Lin, J; Yi, X; Zhou, Q	1
Aligeti, VR; Carroll, RC; Craft, RM; Snider, CC; Wortham, DC	1
Dharmasaroja, PA; Muengtaweepongsa, S; Sae-Lim, S	1
Gremmel, T; Kopp, CW; Koppensteiner, R; Panzer, S; Perkmann, T; Seidinger, D; Steiner, S	1
Andrikopoulou, E; Blumenthal, RS; DeFilippis, AP; Fasoro, YA; Gerstenblith, G; Guallar, E; Jaffe, AS; Kickler, TS; Oloyede, OS; Palachuvattil, JM; Rade, JJ; Saenger, AK; Schulman, SP	1
Filipiak, KJ; Kapłon-Cieślicka, A; Kondracka, A; Opolski, G; Postuła, M; Rosiak, M; Serafin, A	1
Bosco, AA; Carvalho, Md; Duarte, RC; Dusse, LM; Fernandes, AP; Gomes, KB; Gonçalves, LH; Silva, MV	1
Bolli, R; Cambon, A; DeFilippis, AP; Jaffe, AS; Jones, RO; Miles, RJ; Moser, AB; Rai, SN; Schulman, SP	1
Bliden, KP; Ens, G; Franzese, CJ; Gesheff, MG; Gurbel, PA; Guyer, K; Singh, M; Singla, A; Stapleton, D; Tabrizchi, A; Tantry, US; Toth, PP	1
Anand, SS; Chasman, DI; Connolly, SJ; Eikelboom, J; Eriksson, N; Gerstein, HC; Mehta, S; Paré, G; Ridker, PM; Rose, L; Ross, S; Wallentin, L; Yusuf, S	1
Davì, G; Di Marco, M; Di Nicola, M; La Barba, S; Lattanzio, S; Liani, R; Mascellanti, M; Paloscia, L; Pascale, S; Santilli, F	1
Aukrust, P; Consoli, A; Davì, G; Di Fulvio, P; Formoso, G; Lattanzio, S; Liani, R; Santilli, F; Ueland, T; Vazzana, N	1
Becker, S; Campbell, J; Chen, N; Ferro, A; Floyd, CN; Goodman, T; Mustafa, A; Schofield, E; Sharma, P; Ward, M	1
Albisetti, M; Knirsch, W; Kretschmar, O; Kroiss, S; Rand, ML; Schmugge, M; Speer, O	1
Chen, X; Feng, X; Fu, SW; Liu, M; Liu, T; McCaffrey, TA; Zhang, J	1
Bai, ZS; Chen, XH; Feng, XR; Liu, ML; Liu, TF; Zhang, JW	1
Abumiya, T; Furui, E; Hattori, A; Hosomi, N; Isshiki, T; Kada, A; Kaikita, K; Kario, K; Katayama, Y; Kawamura, A; Kimura, K; Kitagawa, K; Minematsu, K; Miyata, S; Miyata, T; Nagao, T; Nagatsuka, K; Nakagawara, J; Nakane, H; Nishikawa, M; Ogawa, H; Okada, H; Saito, K; Takiuchi, S; Tanaka, K; Taomoto, K; Uchiyama, S; Wada, H; Yamawaki, T; Yonemoto, N	1
Berger, J; Diab, Y; Freishtat, R; Klugman, D; Patregnani, J; Sinha, P; Zurakowski, D	1
Bennett-Firmin, J; Bottiglieri, T; Lopez, LR; McCullough, PA; Peterson, M; Schiffmann, R; Swift, C; Vasudevan, A	1
Bennett-Firmin, J; Bottiglieri, T; Lopez, LR; McCullough, PA; Peterson, M; Sathyamoorthy, M; Schiffmann, R; Schussler, JM; Swift, C; Tecson, KM; Vasudevan, A; Velasco, CE	1
Ali Wasti, A; Carresi, C; Coluccio, M; Di Fabrizio, E; Fini, M; Gliozzi, M; Maiuolo, J; Malara, N; Mollace, R; Mollace, V; Muscoli, C; Musolino, V; Rosano, G; Silvestrini, B; Vitale, C	1
Caulfield, M; Fitzgerald, DJ; Ho, E; Howard, P; Hughes, AD; Johnson, T; McCarthy, NS; Munroe, PB; O'Brien, E; Rooney, C; Sever, P; Shields, DC; Stanton, AV; Surendran, P; Thom, S; Treumann, A; Vangjeli, C	1
Bao, L; Che, D; Deng, Q; Fang, Z; Gu, X; Li, J; Li, M; Li, W; Lin, S; Liu, T; Liu, Y; Long, H; Pi, L; Zhang, L; Zhang, Y	1
Eichelberger, B; Gremmel, T; Kopp, CW; Lee, S; Panzer, S	1
Abdus, S; Bai, J; Eikelboom, JW; Gong, X; Gu, Q; Li, C; Lu, Y; Mei, L; Shi, L; Tan, C; Ullah, I; Wang, G; Yang, M; Ye, Z	1
Boucher, AA; Francisco, BJ; Luchtman-Jones, L; Martin, J; Martin, M; Nathan, JD; Pfeiffer, A; Shova, A; Tiao, GM	1
Armitage, J; Aung, T; Bowman, L; Buck, G; Clark, S; Collins, R; Hill, MR; Mafham, M; Parish, S	1

Reviews

4 review(s) available for aspirin and 11-dehydro-thromboxane b2

Article	Year
Monitoring the antiplatelet action of aspirin. JAAPA : official journal of the American Academy of Physician Assistants, 2001, Volume: 14, Issue:5 Topics: Aspirin; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Thromboxane B2	2001
Terms and conditions: semantic complexity and aspirin resistance. Circulation, 2004, Sep-21, Volume: 110, Issue:12 Topics: Aspirin; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cyclooxygenase Inhibitors; Drug Interactions; Drug Resistance; Follow-Up Studies; Genetic Variation; Humans; Patient Compliance; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk; Thromboxane A2; Thromboxane B2; Treatment Failure	2004
Can platelet function tests predict the clinical efficacy of aspirin? Seminars in thrombosis and hemostasis, 2005, Volume: 31, Issue:4 Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Clinical Trials as Topic; Drug Resistance; Flow Cytometry; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Thromboxane B2; Time Factors	2005
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation, 2007, Apr-24, Volume: 115, Issue:16 Topics: Adenosine Diphosphate; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Biomarkers; Biotransformation; Blood Coagulation Tests; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Interactions; Drug Resistance; Hemorrhage; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombosis; Thromboxane A2; Thromboxane B2; Ticlopidine; Treatment Failure	2007

Trials

47 trial(s) available for aspirin and 11-dehydro-thromboxane b2

Article	Year
Importance of reperfusion on thromboxane A2 metabolite excretion after thrombolysis. American heart journal, 1992, Volume: 123, Issue:3 Topics: Aspirin; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Platelet Activation; Streptokinase; Thrombolytic Therapy; Thromboxane A2; Thromboxane B2; Tissue Plasminogen Activator	1992
Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. Thrombosis and haemostasis, 1990, Apr-12, Volume: 63, Issue:2 Topics: Adolescent; Adult; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Coronary Circulation; Drug Therapy, Combination; Electrocardiography; Humans; Isosorbide; Middle Aged; Platelet Activation; Radioimmunoassay; Thromboxane B2	1990
Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. The American review of respiratory disease, 1989, Volume: 140, Issue:4 Topics: 6-Ketoprostaglandin F1 alpha; Adult; Allergens; Aspirin; Blood Platelets; Bronchial Spasm; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Female; Forced Expiratory Volume; Gas Chromatography-Mass Spectrometry; Humans; Male; Placebos; Platelet Activation; Thromboxane A2; Thromboxane B2	1989
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo". Thrombosis and haemostasis, 1994, Volume: 72, Issue:6 Topics: Adult; Aspirin; Blood Platelets; Evaluation Studies as Topic; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Thromboxane A2; Thromboxane B2	1994
Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty. Journal of the American College of Cardiology, 1993, Volume: 21, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cardiac Catheterization; Dose-Response Relationship, Drug; Female; Heparin; Humans; Male; Middle Aged; Models, Cardiovascular; Platelet Activation; Thromboxane A2; Thromboxane B2	1993
Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation, 1996, Jul-01, Volume: 94, Issue:1 Topics: Administration, Cutaneous; Adolescent; Adult; Antioxidants; Ascorbic Acid; Aspirin; Cross-Sectional Studies; Dinoprost; Dose-Response Relationship, Drug; F2-Isoprostanes; Humans; Middle Aged; Nicotine; Oxidative Stress; Smoking; Thromboxane B2; Vitamin E	1996
Increased thromboxane biosynthesis is associated with poststroke dementia. Stroke, 1999, Volume: 30, Issue:8 Topics: Aged; Aspirin; Biomarkers; Blood Platelets; Brain Ischemia; Cerebral Hemorrhage; Chronic Disease; Cognition; Creatinine; Dementia, Vascular; Female; Humans; Male; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Radioimmunoassay; Thromboxane A2; Thromboxane B2	1999
Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus. Arthritis and rheumatism, 1999, Volume: 42, Issue:12 Topics: Adult; Antibodies, Antiphospholipid; Antigens; Aspirin; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Humans; Ischemia; Lupus Erythematosus, Systemic; Male; Middle Aged; Myocardial Infarction; Stroke; Thromboxane B2; Thromboxanes; Tissue Plasminogen Activator; Venous Thrombosis; von Willebrand Factor	1999
Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS. Thrombosis research, 1999, Dec-15, Volume: 96, Issue:6 Topics: Aspirin; Blood Platelets; Chromatography, Affinity; Evaluation Studies as Topic; Gas Chromatography-Mass Spectrometry; Humans; Hydrogen-Ion Concentration; Immunoenzyme Techniques; Male; Reagent Kits, Diagnostic; Reference Values; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Thromboxane B2; Time Factors; Urinalysis	1999
Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation, 2000, Aug-22, Volume: 102, Issue:8 Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprost; Epoprostenol; F2-Isoprostanes; Female; Humans; Isoenzymes; Macrophages; Male; Membrane Proteins; Microscopy, Fluorescence; Muscle, Smooth, Vascular; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Thromboxane A2; Thromboxane B2	2000
Urinary 11-dehydro-thromboxane B(2) and coagulation activation markers measured within 24 h of human acute ischemic stroke. Neuroscience letters, 2001, Nov-02, Volume: 313, Issue:1-2 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Blood Coagulation; Brain Ischemia; Fibrinogen; Humans; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Thromboxane B2	2001
Aspirin and urinary 11-dehydrothromboxane B(2) in African American stroke patients. Stroke, 2002, Volume: 33, Issue:1 Topics: Adult; Aged; Aspirin; Black People; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Stroke; Thromboxane B2	2002
Modulation of aspirin-insensitive eicosanoid biosynthesis by 6-methylprednisolone in unstable angina. Circulation, 2003, Jan-07, Volume: 107, Issue:1 Topics: Adult; Angina, Unstable; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Double-Blind Method; Eicosanoids; Female; Glucocorticoids; Humans; Leukotriene E4; Male; Methylprednisolone; Middle Aged; Myocardial Ischemia; Thromboxane B2	2003
Aspirin dosage and thromboxane synthesis in patients with vascular disease. Pharmacotherapy, 2003, Volume: 23, Issue:5 Topics: Aged; Aspirin; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Platelet Aggregation Inhibitors; Thromboxane B2; Thromboxanes; Vascular Diseases	2003
Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction. Stroke, 2004, Volume: 35, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Black People; Cerebral Infarction; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Predictive Value of Tests; Recurrence; Risk Factors; Thromboxane B2; Ticlopidine	2004
Reduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor. Heart (British Cardiac Society), 2004, Volume: 90, Issue:4 Topics: Adult; Aged; Aspirin; Biomarkers; Cohort Studies; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Electrocardiography, Ambulatory; Female; Humans; Interleukin-6; Macrophage Colony-Stimulating Factor; Male; Middle Aged; Myocardial Ischemia; Peptide Fragments; Platelet Aggregation Inhibitors; Prothrombin; Thromboxane A2; Thromboxane B2	2004
What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke? Cerebrovascular diseases (Basel, Switzerland), 2004, Volume: 17, Issue:4 Topics: Adult; Aged; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Patient Compliance; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Thromboxane B2; Thromboxanes; Treatment Outcome	2004
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. Circulation, 2004, Mar-30, Volume: 109, Issue:12 Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Blood Platelets; Cardiotonic Agents; Cross-Over Studies; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Endothelial Cells; Endothelium, Vascular; Female; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Monocytes; Naproxen; Prostaglandin-Endoperoxide Synthases; Prostaglandins I; Thromboxane B2	2004
Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders. Acta obstetricia et gynecologica Scandinavica, 2004, Volume: 83, Issue:12 Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Hypertension, Pregnancy-Induced; Longitudinal Studies; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pregnancy, High-Risk; Prostaglandins; Thromboxane A2; Thromboxane B2	2004
Platelet activation in patients with colorectal cancer. Prostaglandins, leukotrienes, and essential fatty acids, 2005, Volume: 72, Issue:2 Topics: Aged; Aspirin; Biomarkers; Colorectal Neoplasms; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Female; Humans; Male; Membrane Proteins; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Thromboxane B2	2005
Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. American heart journal, 2005, Volume: 149, Issue:5 Topics: Adult; Aged; Aspirin; C-Reactive Protein; Coronary Disease; Double-Blind Method; Female; Humans; Macrophage Colony-Stimulating Factor; Male; Middle Aged; Peptide Fragments; Prospective Studies; Prothrombin; Smoking; Thromboxane B2	2005
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. Atherosclerosis, 2005, Volume: 183, Issue:2 Topics: Adult; Aged; Aspirin; Biomarkers; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Radioimmunoassay; Retrospective Studies; Salicylates; Thromboxane B2; von Willebrand Factor	2005
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. Journal of the American College of Cardiology, 2006, Jan-17, Volume: 47, Issue:2 Topics: Aged; Aspirin; CD40 Ligand; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Dinoprost; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Platelet Activation; Platelet Aggregation Inhibitors; Radioimmunoassay; Thromboxane A2; Thromboxane B2	2006
Determinants of platelet activation in Alzheimer's disease. Neurobiology of aging, 2007, Volume: 28, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Aspirin; Body Mass Index; C-Reactive Protein; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Cyclooxygenase 2 Inhibitors; Dinoprost; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukin-6; Lactones; Logistic Models; Male; Odds Ratio; Platelet Activation; Radioimmunoassay; Sulfones; Thromboxane B2; Tumor Necrosis Factor-alpha; Vitamin E	2007
Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:6 Topics: Aged; Aspirin; Blood Platelets; Cardiovascular Diseases; Collagen; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Resistance; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Risk Factors; Signal Transduction; Thromboxane B2; Treatment Outcome	2006
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. Clinical pharmacology and therapeutics, 2006, Volume: 80, Issue:3 Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Celecoxib; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Ibuprofen; Male; Middle Aged; Myocardial Ischemia; Osteoarthritis; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Pyrazoles; Sulfonamides; Thromboxane B2; Treatment Outcome	2006
Platelet aggregation and recruitment with aspirin-clopidogrel therapy. Cerebrovascular diseases (Basel, Switzerland), 2008, Volume: 25, Issue:5 Topics: Aspirin; Brain Ischemia; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Stroke; Thromboxane B2; Ticlopidine	2008
Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. Clinical chemistry, 2008, Volume: 54, Issue:6 Topics: Aspirin; Dose-Response Relationship, Drug; Drug Resistance; Humans; Immunoassay; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Thromboxane B2; Time Factors	2008
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. Circulation, 2008, Oct-21, Volume: 118, Issue:17 Topics: Aged; Aspirin; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Internationality; Male; Middle Aged; Risk Factors; Survival Rate; Thromboxane B2; Thromboxanes	2008
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. Thrombosis and haemostasis, 2009, Volume: 101, Issue:4 Topics: Administration, Oral; Adult; Arachidonic Acid; Aspirin; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Resistance; Female; Gene Frequency; Haplotypes; Heterozygote; Homozygote; Humans; Italy; Male; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2; Young Adult	2009
Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone. Thrombosis research, 2010, Volume: 126, Issue:5 Topics: Adolescent; Adult; Aspirin; Female; Humans; Male; Middle Aged; Phytosterols; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2; Young Adult	2010
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. Blood, 2010, Feb-04, Volume: 115, Issue:5 Topics: Adult; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Etoricoxib; Female; Humans; Immunohistochemistry; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyridines; Sulfones; Thrombocythemia, Essential; Thromboxane A2; Thromboxane B2; Thromboxanes; Treatment Outcome	2010
Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT. PloS one, 2010, Feb-19, Volume: 5, Issue:2 Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Celecoxib; Drug Therapy, Combination; F2-Isoprostanes; Female; Humans; Male; Naproxen; Pyrazoles; Sulfonamides; Thromboxane B2; Treatment Outcome	2010
Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2010, Volume: 21, Issue:7 Topics: Adult; Aspirin; Dose-Response Relationship, Drug; Female; Humans; Male; Platelet Aggregation Inhibitors; Sex Factors; Tablets, Enteric-Coated; Thromboxane B2; Time Factors	2010
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. Thrombosis and haemostasis, 2011, Volume: 105, Issue:2 Topics: Aged; Aged, 80 and over; Aspirin; Biomarkers; Blood Platelets; CD40 Ligand; Chi-Square Distribution; Critical Illness; Dinoprost; Drug Administration Schedule; Female; Humans; Iloprost; Inflammation Mediators; Infusions, Intravenous; Ischemia; Italy; Lipid Peroxidation; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Platelet Activation; Platelet Aggregation Inhibitors; Thromboxane B2; Time Factors; Treatment Outcome	2011
[Aspirin resistance in patients with stable ischemic heart disease]. Kardiologiia, 2010, Volume: 50, Issue:11 Topics: Aged; Aspirin; Coronary Angiography; Drug Monitoring; Drug Resistance; Echocardiography, Transesophageal; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Activating Factor; Risk Factors; Severity of Illness Index; Thromboxane B2; Treatment Outcome	2010
Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease. Chinese medical journal, 2011, Volume: 124, Issue:11 Topics: Aged; Aged, 80 and over; Arachidonic Acid; Aspirin; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Genotype; Humans; Male; Membrane Glycoproteins; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIb-IX Complex; Polymerase Chain Reaction; Polymorphism, Genetic; Receptors, Purinergic P2Y1; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane B2	2011
Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications. Thrombosis and haemostasis, 2011, Volume: 106, Issue:3 Topics: Aspirin; Blood Platelets; Cells, Cultured; Clinical Protocols; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Dosage Calculations; Humans; Microvessels; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2	2011
The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus. Journal of thrombosis and haemostasis : JTH, 2012, Volume: 10, Issue:4 Topics: Adult; Aged; Aspirin; Biomarkers; Blood Platelets; Cardiovascular Diseases; Chi-Square Distribution; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Multivariate Analysis; Netherlands; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Regression Analysis; Thromboxane B2; Treatment Outcome	2012
Reversal of the anti-platelet effects of aspirin and clopidogrel. Journal of thrombosis and haemostasis : JTH, 2012, Volume: 10, Issue:4 Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Aspirin; Biomarkers; Blood Platelets; Clopidogrel; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Ontario; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Transfusion; Recovery of Function; Thromboxane B2; Ticlopidine; Time Factors	2012
Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. Circulation journal : official journal of the Japanese Circulation Society, 2013, Volume: 77, Issue:11 Topics: Aged; Aspirin; Blood Platelets; Coronary Artery Disease; Creatinine; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Thrombosis; Thromboxane A2; Thromboxane B2	2013
Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. Kardiologia polska, 2013, Volume: 71, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Blood Platelet Disorders; Blood Platelets; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Logistic Models; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Thromboxane B2	2013
Acetylsalicylic acid therapy: influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels. Clinica chimica acta; international journal of clinical chemistry, 2014, Feb-15, Volume: 429 Topics: Aspirin; Biological Transport; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Hypoglycemic Agents; Insulin Resistance; Intestinal Absorption; Male; Metformin; Middle Aged; Oxidative Stress; Risk Factors; Thromboxane B2	2014
High on Aspirin Platelet Reactivity in Pediatric Patients Undergoing the Fontan Procedure. Circulation, 2016, 10-25, Volume: 134, Issue:17 Topics: Aspirin; Blood Platelets; Child, Preschool; Female; Fontan Procedure; Humans; Male; Platelet Activation; Thrombelastography; Thromboxane B2	2016
Aspirin wears smart. European heart journal. Cardiovascular pharmacotherapy, 2017, 10-01, Volume: 3, Issue:4 Topics: Administration, Sublingual; Animals; Aspirin; Biomarkers; Collagen; Double-Blind Method; Drug Compounding; Fibrinolytic Agents; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Rats; Thromboxane B2	2017
Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis. European journal of clinical pharmacology, 2021, Volume: 77, Issue:12 Topics: Aged; Aspirin; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2	2021
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial. Trials, 2023, Mar-04, Volume: 24, Issue:1 Topics: Aspirin; Cardiovascular Diseases; Diabetes Mellitus; Humans; Thromboxane B2	2023

Other Studies

76 other study(ies) available for aspirin and 11-dehydro-thromboxane b2

Article	Year
Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. The American review of respiratory disease, 1992, Volume: 146, Issue:1 Topics: Adult; Allergens; Aspirin; Asthma; Bronchial Provocation Tests; Female; Histamine; Humans; Leukotriene E4; Male; Middle Aged; SRS-A; Thromboxane B2	1992
Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. Blood, 1992, Oct-15, Volume: 80, Issue:8 Topics: Adult; Aged; Aspirin; Blood Platelets; Female; Humans; Kinetics; Leukotriene E4; Male; Middle Aged; Platelet Activation; Polycythemia Vera; SRS-A; Thromboxane A2; Thromboxane B2	1992
Urinary 11-dehydro-thromboxane B2: a quantitative index of platelet activation in cerebral infarction. Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:6 Topics: Adult; Aged; Arteriosclerosis; Aspirin; Atrial Fibrillation; Carotid Artery Diseases; Cerebral Infarction; Female; Humans; Male; Middle Aged; Platelet Activation; Thromboxane A2; Thromboxane B2	1992
Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke, 1992, Volume: 23, Issue:10 Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aspirin; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Epoprostenol; Female; Humans; Male; Middle Aged; Platelet Aggregation; Thromboxane A2; Thromboxane B2	1992
Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet (London, England), 1990, Mar-31, Volume: 335, Issue:8692 Topics: Adolescent; Adult; Aspirin; Evaluation Studies as Topic; Female; Humans; Hypertension; Platelet Activation; Platelet Count; Pregnancy; Pregnancy Complications, Cardiovascular; Severity of Illness Index; Thromboxane A2; Thromboxane B2	1990
Thromboxane biosynthesis and platelet function in type II diabetes mellitus. The New England journal of medicine, 1990, Jun-21, Volume: 322, Issue:25 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Platelet Aggregation; Thromboxane A2; Thromboxane B2; Thromboxanes	1990
Analysis of multiple thromboxane metabolites in plasma and urine. Advances in prostaglandin, thromboxane, and leukotriene research, 1987, Volume: 17B Topics: Aspirin; Humans; Thromboxane B2; Thromboxanes; Vascular Diseases	1987
Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. Analytical biochemistry, 1986, May-15, Volume: 155, Issue:1 Topics: Adult; Animals; Aspirin; Chromatography, Thin Layer; Deuterium; Gas Chromatography-Mass Spectrometry; Guinea Pigs; Half-Life; Humans; In Vitro Techniques; Male; Prostaglandin-Endoperoxide Synthases; Thromboxane B2	1986
11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. Proceedings of the National Academy of Sciences of the United States of America, 1986, Volume: 83, Issue:16 Topics: Aspirin; Humans; Kinetics; Platelet Aggregation; Thromboxane B2; Thromboxanes; Time Factors	1986
Risk factors for carotid atherosclerosis and platelet activation. Japanese circulation journal, 1994, Volume: 58, Issue:6 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arteriosclerosis; Aspirin; Carotid Artery Diseases; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Multivariate Analysis; Platelet Activation; Risk Factors; Smoking; Thromboxane B2	1994
Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation, 1994, Volume: 89, Issue:5 Topics: Adult; Aspirin; beta-Thromboglobulin; Exercise; Humans; Male; Norepinephrine; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Premedication; Sympathetic Nervous System; Thromboxane B2	1994
Rapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry. Clinical chemistry, 1993, Volume: 39, Issue:12 Topics: Aspirin; Cardiopulmonary Bypass; False Negative Reactions; Gas Chromatography-Mass Spectrometry; Humans; Hydrogen-Ion Concentration; Immunoenzyme Techniques; Platelet Activation; Quality Control; Sensitivity and Specificity; Thromboxane B2	1993
Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man. Prostaglandins, 1993, Volume: 45, Issue:5 Topics: Adult; Aspirin; Blood Platelets; Humans; Male; Reference Values; Smoking; Thromboxane B2; Thromboxanes	1993
Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. The European respiratory journal, 1993, Volume: 6, Issue:3 Topics: Adult; Aspirin; Asthma; Blood Proteins; Bronchial Provocation Tests; Bronchoconstriction; Chymases; Eosinophil Granule Proteins; Eosinophils; Female; Humans; Leukotriene E4; Male; Mast Cells; Methacholine Chloride; Middle Aged; Ribonucleases; Serine Endopeptidases; SRS-A; Thromboxane B2; Tryptases	1993
Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619. Arteriosclerosis and thrombosis : a journal of vascular biology, 1993, Volume: 13, Issue:3 Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Anemia, Sickle Cell; Aspirin; Blood Platelets; Female; Humans; Male; Phosphorylation; Prostaglandin Endoperoxides, Synthetic; Thrombin; Thromboxane A2; Thromboxane B2	1993
Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography-mass spectrometry. Journal of chromatography, 1993, Feb-26, Volume: 612, Issue:2 Topics: Aspirin; Chromatography, Thin Layer; Gas Chromatography-Mass Spectrometry; Humans; Indicators and Reagents; Prostaglandin D2; Solvents; Thromboxane B2	1993
Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris. The American journal of cardiology, 1993, May-15, Volume: 71, Issue:13 Topics: Aged; Aged, 80 and over; Angina, Unstable; Antithrombin III; Aspirin; Blood Coagulation; Female; Humans; Lysine; Male; Middle Aged; Peptide Hydrolases; Platelet Aggregation Inhibitors; Thrombin; Thromboxane B2	1993
Urinary leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma. Allergy, 1997, Volume: 52, Issue:4 Topics: Aspirin; Asthma; Case-Control Studies; Drug Hypersensitivity; Female; Humans; Leukotriene E4; Male; Middle Aged; Severity of Illness Index; Thromboxane B2	1997
Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs. Critical care medicine, 1997, Volume: 25, Issue:7 Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Cyclooxygenase Inhibitors; Embolism, Fat; Epoprostenol; Evaluation Studies as Topic; Hemodynamics; Hypertension, Pulmonary; Lung Diseases; Random Allocation; Swine; Thromboxane A2; Thromboxane B2	1997
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:11 Topics: Antioxidants; Aspirin; Cardiovascular Diseases; Cross-Sectional Studies; Cyclooxygenase Inhibitors; Dinoprost; Female; Humans; Hypercholesterolemia; Isoindoles; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Phenylbutyrates; Platelet Activation; Platelet Aggregation Inhibitors; Reactive Oxygen Species; Thromboxane B2; Vitamin E	1997
Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group. American journal of respiratory and critical care medicine, 1997, Volume: 156, Issue:6 Topics: Aged; Aspirin; Blood Platelets; Creatinine; Cyclooxygenase Inhibitors; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen Inhalation Therapy; Peptide Fragments; Platelet Activation; Prothrombin; Thromboxane B2; Thromboxanes	1997
Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. American journal of respiratory and critical care medicine, 1998, Volume: 158, Issue:6 Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arachidonic Acids; Aspirin; Case-Control Studies; Creatinine; Cross-Sectional Studies; Cyclooxygenase Inhibitors; Dinoprost; Female; Follow-Up Studies; Free Radicals; Humans; Lipid Peroxidation; Lung Diseases, Obstructive; Male; Middle Aged; Oxidative Stress; Oxygen; Sex Factors; Smoking; Thromboxane B2; Time Factors	1998
Increased formation of thromboxane in vivo in humans with mastocytosis. The Journal of investigative dermatology, 1999, Volume: 113, Issue:1 Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Aspirin; beta-Thromboglobulin; Cyclooxygenase Inhibitors; Female; Humans; Male; Methylhistamines; Middle Aged; Platelet Factor 4; Prostaglandins D; Thromboxane B2; Urticaria Pigmentosa	1999
Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method. Prostaglandins & other lipid mediators, 1999, Volume: 58, Issue:5-6 Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aspirin; Dose-Response Relationship, Drug; Epoprostenol; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Pilot Projects; Prostaglandins F; Retinal Artery Occlusion; Retinal Vein Occlusion; Thromboxane A2; Thromboxane B2; Thromboxanes	1999
Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. Allergy, 2001, Volume: 56, Issue:11 Topics: Adult; Aged; Aspirin; Asthma; Bronchial Provocation Tests; Cyclooxygenase Inhibitors; Dinoprost; Female; Forced Expiratory Volume; Humans; Leukotriene E4; Male; Mast Cells; Methylhistamines; Middle Aged; Sensitivity and Specificity; Thromboxane A2; Thromboxane B2; Time Factors	2001
Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. Chest, 2002, Volume: 121, Issue:1 Topics: Adult; Anti-Asthmatic Agents; Aspirin; Asthma; Blood Proteins; Bronchial Provocation Tests; Chromones; Drug Hypersensitivity; Eosinophil Granule Proteins; Eosinophils; Female; Forced Expiratory Volume; Humans; Leukocyte Count; Leukotriene D4; Leukotriene E4; Male; Middle Aged; Ribonucleases; Thromboxane B2	2002
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation, 2002, Apr-09, Volume: 105, Issue:14 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Canada; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Comorbidity; Cyclooxygenase Inhibitors; Death, Sudden, Cardiac; Demography; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thromboxane B2; Thromboxanes; Vitamin E	2002
NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. Circulation, 2002, 12-10, Volume: 106, Issue:24 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Cyclooxygenase 2; Cysteine Proteinase Inhibitors; Drug Administration Schedule; Flow Cytometry; Gastric Mucosa; Interleukin-1; Isoenzymes; Isosorbide Dinitrate; Male; Monocytes; Nitric Oxide; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thromboplastin; Thromboxane B2; Tumor Necrosis Factor-alpha	2002
Aspirin resistance. Circulation, 2002, Dec-10, Volume: 106, Issue:24 Topics: Aspirin; Biomarkers; Cyclooxygenase Inhibitors; Drug Resistance; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Predictive Value of Tests; Risk; Thrombosis; Thromboxane B2; Thromboxanes	2002
Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure? Stroke, 2005, Volume: 36, Issue:2 Topics: Absorption; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Creatinine; Cyclooxygenase 2; Factor XIII; Female; Genetic Variation; Genotype; Humans; Integrin alpha2beta1; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Risk Factors; Thromboxane B2; Time Factors	2005
Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. Thrombosis research, 2005, Volume: 115, Issue:5 Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Aged; Aspirin; Bleeding Time; Blood Coagulation; Cerebral Hemorrhage; Epoprostenol; Female; Humans; Male; Middle Aged; Prospective Studies; Regression Analysis; Thromboxane A2; Thromboxane B2	2005
Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? Basic & clinical pharmacology & toxicology, 2006, Volume: 98, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; C-Reactive Protein; Cholesterol; Coronary Artery Disease; Cross-Sectional Studies; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2; Triglycerides	2006
Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population. The American journal of cardiology, 2006, Sep-15, Volume: 98, Issue:6 Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Aspirin; Coronary Artery Disease; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; Thromboxane B2; Whole Blood Coagulation Time	2006
Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study. Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:1 Topics: Aspirin; Atherosclerosis; Biomarkers; Black or African American; Case-Control Studies; Coronary Disease; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Stroke; Thromboxane B2; United States; White People	2008
Screening for aspirin resistance in stable coronary artery patients by three different tests. Thrombosis research, 2007, Volume: 121, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Bleeding Time; Blood Platelets; Coronary Artery Disease; Drug Evaluation, Preclinical; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Thromboembolism; Thromboxane B2	2007
Aspirin resistance in children with heart disease at risk for thromboembolism: prevalence and possible mechanisms. Pediatric cardiology, 2008, Volume: 29, Issue:2 Topics: Adolescent; Aspirin; Blood Platelets; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Resistance; Female; Follow-Up Studies; Heart Defects, Congenital; Humans; Infant; Male; Platelet Aggregation Inhibitors; Prevalence; Prognosis; Retrospective Studies; Risk Factors; Texas; Thromboembolism; Thromboxane B2	2008
AspirinWorks: a new immunologic diagnostic test for monitoring aspirin effect. Molecular diagnosis & therapy, 2008, Volume: 12, Issue:1 Topics: Aspirin; Cyclooxygenase Inhibitors; Humans; Immunoassay; Reproducibility of Results; Thromboxane B2	2008
Biochemical evaluation of the antiplatelet effect of aspirin in patients at different levels of cardiovascular risk. Bratislavske lekarske listy, 2008, Volume: 109, Issue:4 Topics: Aged; Aspirin; Cardiovascular Diseases; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk; Thromboxane B2	2008
Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease. Journal of thrombosis and thrombolysis, 2010, Volume: 29, Issue:1 Topics: Aged; Aspirin; Blood Platelets; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Thromboxane B2	2010
Letter by cattaneo regarding article, "incomplete inhibition of thromboxane biosynthesis by acetylsalicylic Acid: determinants and effect on cardiovascular risk". Circulation, 2009, Jun-23, Volume: 119, Issue:24 Topics: Aged; Aspirin; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Internationality; Male; Middle Aged; Risk Factors; Survival Rate; Thromboxane B2; Thromboxanes	2009
Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). Thrombosis and haemostasis, 2009, Volume: 102, Issue:2 Topics: Adult; Aspirin; Blood Platelets; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; ROC Curve; Sensitivity and Specificity; Thrombelastography; Thromboxane B2; Young Adult	2009
Aspirin Resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study). The American journal of cardiology, 2009, Aug-15, Volume: 104, Issue:4 Topics: Adult; Aspirin; Cohort Studies; Drug Resistance; Female; Humans; Male; Middle Aged; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Prevalence; Sex Factors; Thromboxane B2	2009
Post interventional cardiology urinary thromboxane correlates with PlateletMapping detected aspirin resistance. Thrombosis research, 2010, Volume: 125, Issue:4 Topics: Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Arachidonic Acid; Aspirin; Blood Platelets; Cardiology; Humans; Platelet Activation; Platelet Count; Thromboxane B2	2010
Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients. European journal of anaesthesiology, 2010, Volume: 27, Issue:7 Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Arachidonic Acid; Aspirin; Blood Coagulation; Blood Platelets; Case-Control Studies; Drug Administration Schedule; Elective Surgical Procedures; Epinephrine; Female; Humans; International Normalized Ratio; Longitudinal Studies; Male; Middle Aged; Partial Thromboplastin Time; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Recovery of Function; Thromboxane B2; Time Factors; Young Adult	2010
The inhibitory effect of statins on urinary 11-dehydrothromboxane levels. International angiology : a journal of the International Union of Angiology, 2010, Volume: 29, Issue:3 Topics: Aged; Aspirin; Atorvastatin; Biomarkers; Blood Glucose; Blood Platelets; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Czech Republic; Down-Regulation; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrroles; Simvastatin; Thromboxane B2; Time Factors; Treatment Outcome; Triglycerides	2010
Aspirin resistance following pediatric cardiac surgery. Thrombosis research, 2010, Volume: 126, Issue:3 Topics: Administration, Oral; Administration, Rectal; Aspirin; Biomarkers; C-Reactive Protein; Cardiac Surgical Procedures; Drug Resistance; Fibrinolytic Agents; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Inflammation Mediators; Logistic Models; New York; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Risk Assessment; Risk Factors; Suppositories; Thrombosis; Thromboxane B2; Time Factors; Treatment Outcome; Up-Regulation	2010
Clinical determinants of aspirin resistance in diabetes. Diabetes research and clinical practice, 2010, Volume: 90, Issue:1 Topics: Albuminuria; Aspirin; Cohort Studies; Diabetic Angiopathies; Drug Resistance; Female; Glycated Hemoglobin; Humans; Insulin Resistance; Male; Middle Aged; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2; Waist Circumference	2010
Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation. Platelets, 2011, Volume: 22, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stents; Thromboxane B2; Treatment Outcome	2011
Urinary 11-dehydro thromboxane B₂ levels in type 2 diabetic patients before and during aspirin intake. Clinica chimica acta; international journal of clinical chemistry, 2011, Jul-15, Volume: 412, Issue:15-16 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Diabetes Mellitus, Type 2; Humans; Male; Middle Aged; Thromboxane B2	2011
Aspirin failure in patients presenting with acute cerebrovascular ischaemia. Thrombosis and haemostasis, 2011, Volume: 106, Issue:2 Topics: Acute Disease; Aged; Aged, 80 and over; Arachidonic Acid; Aspirin; Brain Ischemia; Drug Resistance; Female; Humans; Male; P-Selectin; Patient Compliance; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Thromboxane B2	2011
Aspirin resistance in off-pump coronary artery bypass grafting. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2012, Volume: 41, Issue:1 Topics: Aged; Aspirin; Biomarkers; Case-Control Studies; Coronary Artery Bypass, Off-Pump; Drug Administration Schedule; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Postoperative Care; Postoperative Period; Thrombosis; Thromboxane B2	2012
Aspirin resistance may be associated with adverse pregnancy outcomes. Neuro endocrinology letters, 2011, Volume: 32, Issue:3 Topics: Adult; Aspirin; Cesarean Section; Drug Resistance; Female; Fetal Distress; Humans; Infant, Newborn; Infant, Small for Gestational Age; Lupus Erythematosus, Systemic; Obstetric Labor, Premature; Parity; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Thromboxane B2; Young Adult	2011
Evaluation of effects of low-dose aspirin administration on urinary thromboxane metabolites in healthy dogs. American journal of veterinary research, 2011, Volume: 72, Issue:8 Topics: Animals; Aspirin; Dogs; Enzyme-Linked Immunosorbent Assay; Female; Male; Platelet Aggregation Inhibitors; Thromboxane B2	2011
Urinary 11-dehydro-thromboxane B₂ and 2,3-dinor-6-keto-prostaglandin-F₁α in healthy post-menopausal and pre-menopausal women receiving aspirin 100 mg. Journal of thrombosis and thrombolysis, 2012, Volume: 34, Issue:1 Topics: Adult; Aspirin; Cardiovascular Diseases; Female; Humans; Middle Aged; Platelet Aggregation Inhibitors; Postmenopause; Premenopause; Prostaglandins F; Thromboxane B2	2012
The purification step is not crucial in EIA measurements of thromboxane B2 and 11-dehydrothromboxane B2 in human plasma. Clinical laboratory, 2012, Volume: 58, Issue:1-2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cardiovascular Diseases; Humans; Immunoenzyme Techniques; Platelet Activation; Prognosis; Reagent Kits, Diagnostic; Reproducibility of Results; Solid Phase Extraction; Thromboxane B2	2012
The effect of selected pre-analytical phase variables on plasma thromboxane A₂ measurements in humans. International journal of laboratory hematology, 2013, Volume: 35, Issue:1 Topics: Anticoagulants; Aspirin; Blood Platelets; Citrates; Cyclooxygenase Inhibitors; Humans; Immunoenzyme Techniques; Platelet Aggregation Inhibitors; Specimen Handling; Temperature; Thromboxane A2; Thromboxane B2; Time Factors	2013
Platelet response to aspirin in Chinese stroke patients is independent of genetic polymorphisms of COX-1 C50T and COX-2 G765C. Journal of atherosclerosis and thrombosis, 2013, Volume: 20, Issue:1 Topics: Aged; Aspirin; Base Sequence; Blood Platelets; China; Cyclooxygenase 1; Cyclooxygenase 2; DNA Primers; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Platelet Aggregation; Polymerase Chain Reaction; Prospective Studies; Stroke; Thromboxane B2	2013
A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane. Anesthesia and analgesia, 2013, Volume: 116, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biological Assay; Blood Platelets; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Risk Assessment; Risk Management; Thrombelastography; Thromboxane B2	2013
Aspirin nonresponders in patients with ischaemic stroke. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:4 Topics: Aspirin; Brain Ischemia; Female; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Survival Analysis; Thromboxane B2; Treatment Outcome	2013
Differential impact of inflammation on six laboratory assays measuring residual arachidonic acid-inducible platelet reactivity during dual antiplatelet therapy. Journal of atherosclerosis and thrombosis, 2013, Volume: 20, Issue:7 Topics: Aged; Arachidonic Acids; Aspirin; Blood Platelets; C-Reactive Protein; Electrochemistry; Female; Humans; Immunoassay; Inflammation; Interleukin-6; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Predictive Value of Tests; Risk Factors; Thromboxane B2	2013
Fatty acids and TxA(2) generation, in the absence of platelet-COX-1 activity. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2014, Volume: 24, Issue:4 Topics: Aged; Aspirin; Biomarkers; Blood Platelets; Cardiovascular Diseases; Chromatography, Liquid; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Fatty Acids, Omega-3; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Smoking; Tandem Mass Spectrometry; Thromboxane A2; Thromboxane B2	2014
Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin. Thrombosis and haemostasis, 2014, Volume: 112, Issue:2 Topics: Aged; Aspirin; Biomarkers; Blood Coagulation; Chi-Square Distribution; Coronary Artery Disease; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Lipids; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Sex Factors; Thrombelastography; Thromboxane B2; Treatment Outcome; Ultracentrifugation	2014
Association of cyclooxygenase-2 genetic variant with cardiovascular disease. European heart journal, 2014, Sep-01, Volume: 35, Issue:33 Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aspirin; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Female; Heterozygote; Humans; Male; Multicenter Studies as Topic; Myocardial Infarction; Polymorphism, Genetic; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Thromboxane B2	2014
Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment. Journal of the American Heart Association, 2014, Jul-18, Volume: 3, Issue:4 Topics: Acute Coronary Syndrome; Aged; Aspirin; Calgranulin A; Calgranulin B; Chronic Disease; Dinoprost; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Activation; Platelet Aggregation Inhibitors; Thromboxane B2	2014
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. Journal of the American Heart Association, 2014, Jul-18, Volume: 3, Issue:4 Topics: Aged; Arginine; Aspirin; Biomarkers; Cardiovascular Diseases; Case-Control Studies; CD40 Ligand; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Thromboxane B2; Wnt Signaling Pathway	2014
Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. British journal of clinical pharmacology, 2014, Volume: 78, Issue:2 Topics: Adult; Arachidonic Acid; Aspirin; Blood Platelets; Cohort Studies; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Resistance; Female; Healthy Volunteers; Humans; Integrin beta3; Male; Platelet Aggregation; Thromboxane B2	2014
Monitoring aspirin therapy in children after interventional cardiac catheterization: laboratory measures, dose response, and clinical outcomes. European journal of pediatrics, 2015, Volume: 174, Issue:7 Topics: Adolescent; Arachidonic Acids; Aspirin; Cardiac Catheterization; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance; Female; Humans; Infant; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Thromboxane B2; Young Adult	2015
Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease. Gene, 2015, Oct-15, Volume: 571, Issue:1 Topics: Aged; Aged, 80 and over; Arachidonic Acid; Aspirin; Blood Platelets; Coronary Artery Disease; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Thromboxane B2; Treatment Outcome	2015
[Correlation between the level of the urinary 11-dehydrothromboxane B2 and the clinical efficacy of aspirin in patients with type 2 diabetes and coronary artery disease]. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2015, Dec-18, Volume: 47, Issue:6 Topics: Aspirin; Beijing; Blood Platelets; Coronary Artery Disease; Diabetes Mellitus, Type 2; Humans; Platelet Aggregation Inhibitors; Prospective Studies; Thromboxane B2; Treatment Outcome	2015
Cardiovascular events occur independently of high on-aspirin platelet reactivity and residual COX-1 activity in stable cardiovascular patients. Thrombosis and haemostasis, 2016, 08-01, Volume: 116, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Cardiovascular Diseases; Cohort Studies; Cyclooxygenase 1; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Risk Factors; Secondary Prevention; Thromboxane B2	2016
Oxidative stress reflected by increased F Thrombosis research, 2016, Volume: 148 Topics: Aged; Aspirin; Coronary Artery Disease; Cross-Sectional Studies; Cyclooxygenase 1; Dinoprost; F2-Isoprostanes; Female; Humans; Male; Middle Aged; Oxidative Stress; Platelet Aggregation Inhibitors; Thromboxane B2	2016
Residual thromboxane activity and oxidative stress: influence on mortality in patients with stable coronary artery disease. Coronary artery disease, 2017, Volume: 28, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Cause of Death; Coronary Artery Disease; Cyclooxygenase Inhibitors; Dinoprost; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oxidative Stress; Prognosis; Prospective Studies; Risk Factors; Survival Rate; Texas; Thromboxane B2; Time Factors	2017
Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A Atherosclerosis, 2018, Volume: 269 Topics: Aged; Aspirin; Cardiovascular Agents; Cardiovascular Diseases; Carrier Proteins; Contactins; Europe; Female; Gene Frequency; Genetic Markers; Genetic Predisposition to Disease; Genome-Wide Association Study; Haplotypes; Humans; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Phenotype; Polymorphism, Single Nucleotide; Primary Prevention; Progression-Free Survival; Randomized Controlled Trials as Topic; Risk Factors; RNA-Binding Proteins; Thromboxane A2; Thromboxane B2; Time Factors; White People	2018
Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease. Drug design, development and therapy, 2018, Volume: 12 Topics: Aspirin; Blood Platelets; CD40 Ligand; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Male; Mucocutaneous Lymph Node Syndrome; P-Selectin; Platelet Aggregation Inhibitors; Thromboxane B2	2018
Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity. Vascular pharmacology, 2021, Volume: 136 Topics: Aged; Angioplasty; Aspirin; Biomarkers; Blood Platelets; Cardiovascular Diseases; Dual Anti-Platelet Therapy; Female; Flow Cytometry; Humans; Male; Middle Aged; Obesity; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thromboxane B2; Time Factors; Treatment Outcome	2021
Urinary 11-dehydrothromboxane B2 aspirin efficacy testing is sensitive to perioperative inflammation in pediatric solid-organ transplant patients. Pediatric blood & cancer, 2022, Volume: 69, Issue:2 Topics: Adolescent; Adult; Aspirin; Blood Platelets; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Inflammation; Organ Transplantation; Pediatrics; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Thromboxane B2; Young Adult	2022